The race to nowhere

WASHINGTON - In a race that Biotechnology Industry Organization President Carl Feldbaum likens to the proverbial match between the tortoise and the hare, FDA reform and reauthorization of the Prescription Drug User Fee Act (PDUFA) is moving forward in the House but remains

Read the full 438 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE